Skip to Content

IG 271 1.25mg (Ramipril 1.25 mg)

Pill imprint IG 271 1.25mg has been identified as Ramipril 1.25 mg.

Ramipril is used in the treatment of high blood pressure; left ventricular dysfunction; diabetic kidney disease; cardiovascular risk reduction; heart attack (and more), and belongs to the drug class angiotensin converting enzyme inhibitors. There is positive evidence of human fetal risk during pregnancy. Ramipril 1.25 mg is not a controlled substance under the Controlled Substance Act (CSA).

Ramipril 1.25 mg IG 271 1.25mg
Ramipril 1.25 mg IG 271 1.25mg
Discount Card Promo
Ramipril
Imprint:
IG 271 1.25mg
Strength:
1.25 mg
Color:
Yellow
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Angiotensin converting enzyme inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Manufacturer:
InvaGen Pharmaceuticals, Inc.
National Drug Code (NDC):
67787-0271
Inactive Ingredients:
pregelatinized starch
gelatin
titanium dioxide
D&C Yellow No. 10
FD&C Yellow No. 6

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide